That's strange about the vit D my daughter , with PA, has been put on it as well
Potential risks include changes in growth hormones, abnormal tissue growth, or interference with Tissue Regeneration pathways
GHK-Cus systemic approach means injectable formulations provide benefits beyond the scalp
XRPD, X-ray powder diffraction
Just ensure that you pinch the skin if the injection site is too lean
3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy